| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.07 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.11 | 0.08 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.093 | 0.08 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.066 | 0.08 |